Manufacturing and Biosafety Testing for Every Stage of Gene Therapy Development
Gene therapy and gene-modified cell therapy developers like you are providing life-saving therapies to many patients. A critical part of your development process is the establishment of biosafety tests to characterize the cell and virus products going into the manufacturing process, as well as the QC and release testing of clinical batches.
Offering a broad range of services, BioReliance® services support every stage of gene therapy development – from cGMP viral vector process development and manufacturing to a comprehensive set of biosafety tests in accordance with regulatory guidelines. Applying state of the art techniques such as droplet digital PCR as well as established methods to gene therapy testing provides enhanced safety and quality reassurance.